Page last updated: 2024-11-04

linsidomine and Leukemia, Lymphoid

linsidomine has been researched along with Leukemia, Lymphoid in 1 studies

linsidomine: RN given refers to parent cpd; structure

Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.

Research Excerpts

ExcerptRelevanceReference
"Pyrrolidine dithiocarbamate (PDTC) was cytotoxic on its own and inhibited NF-kappaB activity."1.31Killing of lymphoblastic leukemia cells by nitric oxide and taxol: involvement of NF-kappaB activity. ( Assreuy, J; Sampaio de Freitas, M; Santos-Silva, MC, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santos-Silva, MC1
Sampaio de Freitas, M1
Assreuy, J1

Other Studies

1 other study available for linsidomine and Leukemia, Lymphoid

ArticleYear
Killing of lymphoblastic leukemia cells by nitric oxide and taxol: involvement of NF-kappaB activity.
    Cancer letters, 2001, Nov-08, Volume: 173, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Cytoskeleton; Drug Synergism; Humans; Leuk

2001